Toxicology Lab Billing: Medical Necessity, Frequency Limits and Coding
A toxicology lab can run a clean panel, report on time and still not get paid. Most drug testing denials have nothing to do with the science. They come from the order, the code and how often the test was run. If your toxicology lab billing team is fighting the same denials every month, the fix usually starts before the specimen ever reaches the bench.
Here is where drug testing claims go wrong in 2027, and what to change now.
Presumptive vs definitive: bill what was actually done
Medicare splits drug testing into two families. Presumptive testing (CPT 80305, 80306 and 80307) is the screen. It is billed once per date of service, and the code depends on the method: direct optical observation, instrument chemistry analyzers, or more complex instrumented methods.
Definitive testing identifies the specific drug. For Medicare it is billed with HCPCS G0480 through G0483, based on how many drug classes were tested: 1 to 7, 8 to 14, 15 to 21, or 22 or more.
The common mistakes:
- Billing a higher presumptive code than the method supports
- Billing two presumptive codes on the same date of service
- Counting drugs instead of drug classes when choosing the G code
- Billing a definitive class count that the order and the report don't both support
Medical necessity lives in the order
Your MAC's drug testing coverage policy expects the ordering provider to say which drugs or classes to test and why. Payers read the order, not your menu.
Three patterns draw the most denials:
- Standing orders that send every patient to the same full panel, with no patient-specific reason
- Reflex to definitive on every class, even when the presumptive screen was negative and the provider didn't ask for confirmation
- Missing diagnosis detail, where the claim says "drug screening" but the record never explains the clinical reason
Look up your MAC's controlled substance monitoring and drug testing policy in the Medicare Coverage Database, and build your requisition around it. A requisition that asks the right questions prevents more denials than any appeal.
Frequency limits catch good claims
Coverage policies limit how often definitive testing is covered for the same patient, and the limits differ by phase of treatment. A patient tested weekly early in treatment may only be covered monthly later. When your billing system doesn't track the patient's testing history, claims that were medically sound still deny for frequency.
Fix it on the front end. Flag patients who are close to their limit before the specimen runs, and give ordering providers a way to document why more frequent testing is needed.
NCCI edits and bundling
CMS's National Correct Coding Initiative edits stop some code pairs from paying on the same date of service. Specimen validity testing is a common example: for Medicare it is part of the drug test, not a separate charge. Billing it separately invites denials and can look like unbundling on an audit.
Run every claim through current NCCI edits before it goes out, and review your charge master each quarter when the edits update.
2027 makes every denial more expensive
CMS's preliminary 2027 Clinical Laboratory Fee Schedule rates cut many tests by up to 15%. When the rate per test drops, a lab can't afford to lose claims to fixable coding and order problems. We broke down what the cuts mean in 2027 Medicare Lab Fee Schedule Cuts: How Labs Are Preparing.
A quick checklist for toxicology claims
- Match the presumptive code to the method you actually used, once per date of service
- Count drug classes, not drugs, for G0480 to G0483
- Require a patient-specific reason on every order, and drop blanket standing orders
- Reflex to definitive only when the order allows it
- Track each patient's testing frequency against your MAC's policy
- Run NCCI edits before submission, and stop billing specimen validity separately for Medicare
- Review your top denial reasons every month and fix the cause upstream
See where your lab is losing money
The lab team at Advanced Data Systems works toxicology, molecular and clinical lab claims every day, alongside our revenue cycle management team. Book a Complimentary Laboratory Performance Review: a free 15-minute session where we look at your denial trends and the codes costing you the most. Schedule your review or call 1-800-899-4237 ext 2264.
About Jim O'Neill
As the company’s Laboratory Services Business Development Manager, Jim has 30 years’ experience in LIS and financial systems including 20 years as the owner of CSS (Avalon LIS). With a Bachelor’s degree in information technology from Rowan University, Jim has worked / consulted with over 500 labs in the US and internationally in improving their LIS and financial solutions. Jim is genuinely people-oriented and civic-minded; he’s the former Mayor of Northfield NJ and is currently on the town’s council. Feel free to reach out to me at 1-800-899-4237 ext. 2264